|
Amplification of cortical
serotonin release: a further neurochemical action of the vigilance-promoting
drug modafinil
Ferraro L, Fuxe K, Tanganelli S,
Fernandez M, Rambert FA, Antonelli T
Department of Experimental and Clinical Medicine,
Section of Pharmacology, University of Ferrara,
Ferrara, Italy
Neuropharmacology 2000 Oct 1; 39(11):1974-1983
ABSTRACT
The present in vitro and in vivo studies
examined the effects of modafinil on serotonergic transmission in the rat
frontal cortex. In the in vitro study modafinil (0.3-30 muM) increased
electrically-evoked, but not spontaneous, serotonin ([(3)H]5-HT) efflux from
cortical slices in a concentration-dependent manner while the indirect
serotonin agonist dl-fenfluramine (1-15 muM) enhanced both spontaneous and
evoked [(3)H]5-HT efflux. The effects of modafinil were more pronounced when
the 5-HT reuptake was blocked by paroxetine. Contrary to paroxetine (0.3-3
muM) and dl-fenfluramine (1-5 muM), modafinil failed to influence the
[(3)H]5-HT uptake. In the in vivo study modafinil (3-100 mg/kg i.p.)
increased 5-HT dialysate levels, the maximal effect being already reached at
the 30 mg/kg dose. dl-fenfluramine (5 mg/kg) induced an increase in 5-HT
levels which was significantly higher than that displayed by modafinil at 30
mg/kg. In the presence of paroxetine (3 muM), the effect of modafinil at 30
mg/kg was higher than that observed in the absence of 5-HT reuptake
inhibition. Finally, in the presence of the selective 5-HT(1A) receptor
agonist 8-OH-DPAT, modafinil at 100 mg/kg failed to affect 5-HT dialysate
levels.These results demonstrate that modafinil regulates cortical
serotonergic transmission and suggest that the drug preferentially acts by
amplifying the electro-neurosecretory coupling mechanisms and via mechanisms
which do not involve the reuptake process.
-
Modafinil research
1. Modafinil for
sustaining the alertness of helicopter pilots
2. Modafinil augmentation
of antidepressant treatment
3. Modafinil the
unique properties of a new stimulant
4. Modafinil children
with attention-deficit/hyperactivity disorder
5. Modafinil tolerability
in healthy male volunteers
6. Modafinil successful
treatment of hypersomnia & narcolepsy
7. Modafinil narcolepsy:
symptoms and management
8. Modafinil
amplification of cortical serotonin release
9. Modafinil
treatment of alcoholic organic brain syndrome
10. Modafinil
effect on melatonin, cortisol, and growth hormone
11. Modafinil
in obstructive sleep apnea-hypopnea syndrome
International
Antiaging Systems
Les Autelets Suite A
Sark GY9 0SF
Channel Islands
Great Britain
phone: 44-870-151-4144 (Britain)
contact us
we
do not accept telephone orders
we do not ship to the United
Kingdom
|